メニュー 戻るLS40 Promoting DX (Digital Transformation) in Risk Communication to Patients

19th DIA Japan Annual Meeting 2022

New “Quest for the future”~Moving Creativity and Innovation Forward in “New Normal”~

価格は消費税抜きとなっております。

LS40 Promoting DX (Digital Transformation) in Risk Communication to Patients

Session Chair(s)

Kazuhiko  Ishida, MSc, RPh

Kazuhiko Ishida, MSc, RPh

  • Director, Pharmacovigilance
  • Astellas Pharma Inc., Japan

Speaker(s)

Michiko  Yamamoto, PhD

Michiko Yamamoto, PhD

  • Visiting Professor
  • Kumamoto University, Japan
Shinya  Takemoto, MSc

Shinya Takemoto, MSc

  • Group Manager, Safety Information Strategy Group, Risk Communication Department
  • Chugai Pharmaceutical Co., Ltd., Japan